Corryn Biotechnologies Ltd 13184878 false 2023-03-01 2024-02-29 2024-02-29 The principal activity of the company is research and experimental development on biotechnology. Digita Accounts Production Advanced 6.30.9574.0 true 13184878 2023-03-01 2024-02-29 13184878 2024-02-29 13184878 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 13184878 bus:Micro-entities 2023-03-01 2024-02-29 13184878 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 13184878 bus:FullAccounts 2023-03-01 2024-02-29 13184878 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 13184878 bus:RegisteredOffice 2023-03-01 2024-02-29 13184878 bus:Director1 2023-03-01 2024-02-29 13184878 bus:Director2 2023-03-01 2024-02-29 13184878 bus:Director3 2023-03-01 2024-02-29 13184878 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 13184878 countries:EnglandWales 2023-03-01 2024-02-29 13184878 2022-03-01 2023-02-28 13184878 2023-02-28 13184878 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 iso4217:GBP xbrli:pure

Registration number: 13184878

Corryn Biotechnologies Ltd

Unaudited Filleted Financial Statements

for the Year Ended 29 February 2024

 

Corryn Biotechnologies Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

2

 

Corryn Biotechnologies Ltd

Company Information

Directors

L D Burke

L Grandidier

F Zomer Volpato

Registered office

Bay Technology Centre
Central Avenue
Baglan
Port Talbot
SA12 7AX

Accountants

Chisnall Comer Ismail and Co
Chartered Accountants
Maria House
35 Millers Road
Brighton
BN1 5NP

 

Corryn Biotechnologies Ltd

(Registration number: 13184878)
Balance Sheet as at 29 February 2024

2024
£

2023
£

Fixed assets

1,131

1,209

Current assets

44,148

15,733

Prepayments and accrued income

2,425

-

Creditors: Amounts falling due within one year

(33,135)

(4,138)

Net current assets

13,438

11,595

Total assets less current liabilities

14,569

12,804

Accruals and deferred income

(2,750)

(750)

 

11,819

12,054

Capital and reserves

11,819

12,054

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Bay Technology Centre
Central Avenue
Baglan
Port Talbot
SA12 7AX
Wales

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 4 (2023 - 1).

For the financial year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

Corryn Biotechnologies Ltd

(Registration number: 13184878)
Balance Sheet as at 29 February 2024

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 27 September 2024 and signed on its behalf by:




 

.........................................

L D Burke

Director